Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices
Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in... see more

Recent & Breaking News (GREY:LXXGQ)

LexaGene (TSXV:LXG) verifies CDC monkeypox assay works on MiQLab system

Jonathon Brown August 29, 2022

LexaGene Verifies CDC Monkeypox Assay Works on MiQLab System and Readies Company Should an EUA be Declared

GlobeNewswire August 29, 2022

LexaGene's (TSXV:LXG) MiQLab System generates results in as little as 30 minutes

Shoran Devi August 24, 2022

LexaGene's MiQLab System Generates Leptospira Results in as Soon as 30 minutes using Isothermal Chemistry

GlobeNewswire August 24, 2022

The University of Penn Vet to evaluate a new gastrointestinal panel using LexaGene's (TSXV:LXG) MiQLab System

Brieanna McCutcheon  August 17, 2022

University of Pennsylvania's School of Veterinary Medicine to Evaluate New Gastrointestinal Panel Using LexaGene's MiQLab System

GlobeNewswire August 17, 2022

LexaGene (TSXV:LXG) reduces MiQLab's time-to-result by 35 per cent

Shoran Devi August 10, 2022

LexaGene Reduces Time-to-Result by ~35%

GlobeNewswire August 10, 2022

LexaGene Announces Filing of Financial Statements, Revocation of MCTO & the Granting of Incentive Equity Awards to Employees

GlobeNewswire July 29, 2022

LexaGene Completes Multi-Center Validation Study Using MiQLab® System for Diagnosing Urinary Tract Infections

GlobeNewswire July 27, 2022

LexaGene Provides MCTO Update

GlobeNewswire July 12, 2022

LexaGene (TSXV:LXG) to host a webinar on the use of the MiQLab system to diagnose urinary tract infections

Brieanna McCutcheon  July 5, 2022

LexaGene Announces Webinar by UC Davis Professor on Use of MiQLab® System for Diagnosis of Urinary Tract Infections

GlobeNewswire July 5, 2022

LexaGene (TSXV:LXG) has MiQLab Systems operating in 10 states

Brieanna McCutcheon  July 4, 2022

LexaGene Announces MiQLab® System Sale to Veterinary Hospital in Wisconsin

GlobeNewswire July 1, 2022

LexaGene Announces Management Cease Trade Order

GlobeNewswire June 30, 2022

LexaGene Files Form 10 Registration Statement with the SEC and Announces a Delay in Filing Year-End Annual Canadian Financial Filings

GlobeNewswire June 28, 2022

LexaGene announces (TSXV:LXG) multi-system purchase

Shoran Devi May 25, 2022

LexaGene Announces Multi-System Purchase from a Large Market Leader in Animal Health

GlobeNewswire May 25, 2022

LexaGene Successfully Completes CRADA with US Army

GlobeNewswire May 3, 2022